GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Can Fite Biofarma Ltd (AMEX:CANF) » Definitions » Non Operating Income

CANF (Can Fite Biofarma) Non Operating Income : $0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Can Fite Biofarma Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. Can Fite Biofarma's Non Operating Income for the three months ended in Dec. 2024 was $0.00 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2024 was $0.00 Mil.

Can Fite Biofarma Non Operating Income Historical Data

The historical data trend for Can Fite Biofarma's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Can Fite Biofarma Non Operating Income Chart

Can Fite Biofarma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.22 -0.28 0.07 -0.03

Can Fite Biofarma Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Dec24
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Can Fite Biofarma Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Can Fite Biofarma Non Operating Income Related Terms

Thank you for viewing the detailed overview of Can Fite Biofarma's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Can Fite Biofarma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Can Fite Biofarma Ltd (AMEX:CANF) » Definitions » Non Operating Income
Comparable Companies
XTAE:CBI XTAE:BLRX XTAE:MTLF XTAE:EVGN XTAE:XTLB XTAE:BOLT XTAE:PPBT XTAE:PLNT XTAE:HDST-M XTAE:KDST VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX
Traded in Other Exchanges
CANF:Israel
Address
26 Ben Gurion Street, Ramat Gan, ISR, 5257346
Website
http://www.canfite.com
Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The company's platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. The company's drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).